- Home
- SNYR vs ASBP Comparison
SNYR vs ASBP Comparison
Compare SNYR & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNYR
- ASBP
- Stock Information
- Founded
- SNYR 2010
- ASBP 2021
- Country
- SNYR United States
- ASBP United States
- Employees
- SNYR N/A
- ASBP N/A
- Industry
- SNYR
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- SNYR
- ASBP Health Care
- Exchange
- SNYR NYSE
- ASBP Nasdaq
- Market Cap
- SNYR 16.6M
- ASBP 14.5M
- IPO Year
- SNYR N/A
- ASBP N/A
- Fundamental
- Price
- SNYR $3.16
- ASBP $0.33
- Analyst Decision
- SNYR Strong Buy
- ASBP
- Analyst Count
- SNYR 1
- ASBP 0
- Target Price
- SNYR $10.00
- ASBP N/A
- AVG Volume (30 Days)
- SNYR 107.9K
- ASBP 7.6M
- Earning Date
- SNYR 08-24-2025
- ASBP 08-24-2025
- Dividend Yield
- SNYR N/A
- ASBP N/A
- EPS Growth
- SNYR N/A
- ASBP N/A
- EPS
- SNYR 0.30
- ASBP N/A
- Revenue
- SNYR $33,592,914.00
- ASBP N/A
- Revenue This Year
- SNYR $37.83
- ASBP N/A
- Revenue Next Year
- SNYR $18.39
- ASBP N/A
- P/E Ratio
- SNYR $10.26
- ASBP N/A
- Revenue Growth
- SNYR N/A
- ASBP N/A
- 52 Week Low
- SNYR $0.36
- ASBP $0.22
- 52 Week High
- SNYR $10.00
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- SNYR N/A
- ASBP N/A
- Support Level
- SNYR N/A
- ASBP N/A
- Resistance Level
- SNYR N/A
- ASBP N/A
- Average True Range (ATR)
- SNYR 0.00
- ASBP 0.00
- MACD
- SNYR 0.00
- ASBP 0.00
- Stochastic Oscillator
- SNYR 0.00
- ASBP 0.00
About SNYR SYNERGY CHC CORP
Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.